The invention relates to a pharmaceutical composition consisting of snail slime Helix aspersa muller (Cryptomphalus aspersus) (20% to 50%), camomile extract (1-4%), propolis 1l-4%), and pharmaceutically acceptable excipients and/or additives for forming a formulation of low, intermediate or high viscosity (10 to 1000 Pa-s). Said composition is in the form of a lotion, soap, cream or gel, which is embedded in a gauze-type fabric in the form of a plaster that can be applied to lesions caused by the different types of rosacea. The composition can also contain natural extracts such as marigold extract, honey and vegetable oils. The invention also relates to the method for producing the composition and to the use thereof for preparing a medicament or device for preventing, treating or curing lesions caused by rosacea, on the skin of the face or the body.

A therapeutic composition for various skin conditions having a mixture of at least some or all of the active ingredients, said active ingredients including clotrimazole, gentamicin, betamethasone, zinc oxide, sulfathiazole, ketoconazole, lanolin, alhucema or lavender, aloe vera, rosemary, tepezcohuite, semialarium mexicanum and commercial sulfur.

This disclosed method improves the accuracy of testing blood for the levels of contaminant, such as lead, cadmium and mercury, in individuals. The method comprises cleaning the area where the skin will be penetrated to obtain the blood sample to remove the contaminant to be measured in the blood. The cleansing is accomplished with a cleanser formulated to remove the contaminant to be measured in the blood from the surface of the skin, the pores, sweat ducts, hair follicles and sebaceous gland ducts. The method reduces contamination of the blood sample by contaminants on, and/or in the portion of the skin through which the blood sample is drawn. A premoistened wipe can also be used that mobilizes heavy metals from the skin surface, the skin pores, sweat ducts, hair follicles and sebaceous gland ducts, and is formed with a wipe substrate material selected for its affinity to bind the toxic materials.

Described herein are pharmaceutical compositions comprising one or more modulators of a cytochrome 450 enzyme (CYP450) and substituted or unsubstituted diindolylmethane. Also described herein are methods for treating one or more skin conditions by administering a combination therapy comprising substituted or unsubstituted diindolylmethane and one or more modulators of CYP450. In particular, methods are disclosed for improving bioavailability and pharmacokinetic parameters of substituted or unsubstituted diindolylmethane following the combination therapy.

An emollient composition comprising at least one hydrocarbon fluid in an amount of 50 to 100% by weight relative to the total weight of the composition is provided. The fluid can be obtained by a process of catalytically hydrogenating a feed comprising more than 85% by weight of oligomerized olefins, at a temperature from 115 to 195° C. and at a pressure from 30 to 70 bars. A cosmetic, dermatological or pharmaceutical composition comprising the emollient composition and uses thereof are also provided.

An emollient composition comprising at least one hydrocarbon fluid in an amount of 50 to 100% by weight relative to the total weight of the composition is provided. The fluid can be obtained by a process of catalytically hydrogenating a feed comprising more than 85% by weight of oligomerized olefins, at a temperature from 115 to 195° C. and at a pressure from 30 to 70 bars. A cosmetic, dermatological or pharmaceutical composition comprising the emollient composition and uses thereof are also provided.

Compositions and methods for skincare treatment are provided. The invention relates more generally to skin care treatment and more particularly, to compositions and methods for promoting healthy skin, skin regeneration, skin repair, skin bed preparation, and enhanced wound healing.

Compositions and methods for skincare treatment are provided. The invention relates more generally to skin care treatment and more particularly, to compositions and methods for promoting healthy skin, skin regeneration, skin repair, skin bed preparation, and enhanced wound healing.

Methods and formulations for increasing the water solubility and/or bioavailability of a lipophilic natural compounds is disclosed. The formulations may be employed to make liquid filled capsules or clear and stable beverages containing therapeutic amounts of the active ingredients, for example.

Methods and formulations for increasing the water solubility and/or bioavailability of a lipophilic natural compounds is disclosed. The formulations may be employed to make liquid filled capsules or clear and stable beverages containing therapeutic amounts of the active ingredients, for example.